Global Whole Exome Sequencing Market, By Products and Services (Products, Systems, Kits, Services, Sequencing Services, Data Analysis Services, Others), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Others), Applications (Diagnostics, Cancer, Drug Discovery and Development, Others), End User (Research Center, Academic and Government Institutions, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
The whole exome sequencing market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with the CAGR of 11.4% in the forecast period of 2021 to 2028. The increase in number of research and development activities to enhance scientific applications is escalating the growth of whole exome sequencing market.
Exome sequencing refers to a technique for sequencing all of the exome and protein-coding genes in a genome. This technique consists of selecting of the sub-set of DNA that encodes proteins or exons followed by sequencing of the exonic DNA via high-throughput DNA sequencing methods. Exome sequencing is utilized in the identification of genetic variants responsible for diseases including miller syndrome and Alzheimer’s disease.
The rise in the application of whole-exome sequencing in clinical diagnosis, growing rate of research and development activities in the field of genomics and next-generation sequencing and surge in demand for personalized medicine are the major factors driving the whole exome sequencing market. The increasing adoption of next-generation sequencing methods for prediction, treatment and monitoring of diverse chronic diseases including cancer among others and rise in the popularity of the whole exome sequencing owning to low cost and high speed accelerate the whole exome sequencing market growth. The rising acquisitions and mergers among key players and increase in the investment and funding in research and development programs by biotechnology companies and pharmaceutical companies influence the whole exome sequencing market. Additionally, high demand for the diagnosis of rare diseases and increasing number of new scientific applications positively affect the whole exome sequencing market. Furthermore, technological advancements in whole-exome sequencing techniques and demand for personalized medicine extend profitable opportunity to the whole exome sequencing market players in the forecast period of 2021 to 2028.
On the other hand, the ethical and legal issues associated with the whole exome sequencing and high reliability on grants is the factors expected to obstruct the whole exome sequencing market growth. The need for skilled professionals is projected to challenge the whole exome sequencing market in the forecast period of 2021 to 2028.
This whole exome sequencing market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on whole exome sequencing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Whole Exome Sequencing Market Scope and Market Size
The whole exome sequencing market is segmented on the basis of products and services, technology, applications and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of products and services, the whole exome sequencing market is segmented into products, systems, kits, services, sequencing services, data analysis services and others. Kits are further segmented into DNA fragmentation end repair, A-tailing and size selection, library preparation kits and target enrichment kits.
- On the basis of technology, the whole exome sequencing market is segmented into sequencing by synthesis, ion semiconductor sequencing and others.
- On the basis of applications, the whole exome sequencing market is segmented into diagnostics, cancer, drug discovery and development and others.
- On the basis of end user, the whole exome sequencing market is segmented into research center, academic and government institutions, hospitals and clinics, pharmaceutical and biotechnology companies and others.
Global Whole Exome Sequencing Market Country Level Analysis
The whole exome sequencing market is analyzed and market size insights and trends are provided by country, products and services, technology, applications and end user as referenced above.
The countries covered in the global whole exome sequencing market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the whole exome sequencing market because of the increasing prevalence of genetic and chronic disorders, high demand for targeted and personalized medicine, aging population and favorable government initiatives in the region. Asia-Pacific is expected to witness the highest CAGR in the forecast period of 2021-2028 because of the government funding and large numbers of conferences related to the whole exome sequencing technique in the region.
The country section of the whole exome sequencing market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The whole exome sequencing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for whole exome sequencing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the whole exome sequencing market. The data is available for historic period 2011-2019.
Competitive Landscape and Whole Exome Sequencing Market Share Analysis
The whole exome sequencing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to whole exome sequencing market.
The major players covered in the whole exome sequencing market report are llumina, Inc., Thermo Fisher Scientific, Inc., Roche NimbleGen, Inc., Agilent Technologies, Beijing Genomics Institute, Eurofins Genomics, Inc., Sengenics, GENEWIZ, Inc., Knome, Inc., Macrogen, Inc., Ambry Genetics, Merck KGaA, Quantum Biosystems, Trace Genomics, Inc., ALLSEQ, INC., Bio-Rad Laboratories, Inc., MicroGen Diagnostics among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Global Whole Exome Sequencing Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.